1. Home
  2. AGAE vs NTRB Comparison

AGAE vs NTRB Comparison

Compare AGAE & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGAE
  • NTRB
  • Stock Information
  • Founded
  • AGAE 2017
  • NTRB 2016
  • Country
  • AGAE United States
  • NTRB United States
  • Employees
  • AGAE N/A
  • NTRB N/A
  • Industry
  • AGAE Cable & Other Pay Television Services
  • NTRB Industrial Specialties
  • Sector
  • AGAE Telecommunications
  • NTRB Health Care
  • Exchange
  • AGAE Nasdaq
  • NTRB Nasdaq
  • Market Cap
  • AGAE 49.6M
  • NTRB 77.9M
  • IPO Year
  • AGAE N/A
  • NTRB N/A
  • Fundamental
  • Price
  • AGAE $1.21
  • NTRB $8.09
  • Analyst Decision
  • AGAE
  • NTRB
  • Analyst Count
  • AGAE 0
  • NTRB 0
  • Target Price
  • AGAE N/A
  • NTRB N/A
  • AVG Volume (30 Days)
  • AGAE 27.0K
  • NTRB 51.8K
  • Earning Date
  • AGAE 11-07-2024
  • NTRB 12-11-2024
  • Dividend Yield
  • AGAE N/A
  • NTRB N/A
  • EPS Growth
  • AGAE N/A
  • NTRB N/A
  • EPS
  • AGAE N/A
  • NTRB N/A
  • Revenue
  • AGAE $8,212,441.00
  • NTRB $1,803,816.00
  • Revenue This Year
  • AGAE N/A
  • NTRB N/A
  • Revenue Next Year
  • AGAE N/A
  • NTRB N/A
  • P/E Ratio
  • AGAE N/A
  • NTRB N/A
  • Revenue Growth
  • AGAE 13.37
  • NTRB N/A
  • 52 Week Low
  • AGAE $0.61
  • NTRB $1.53
  • 52 Week High
  • AGAE $1.57
  • NTRB $9.60
  • Technical
  • Relative Strength Index (RSI)
  • AGAE 41.08
  • NTRB 74.22
  • Support Level
  • AGAE $1.20
  • NTRB $6.17
  • Resistance Level
  • AGAE $1.30
  • NTRB $8.25
  • Average True Range (ATR)
  • AGAE 0.07
  • NTRB 0.56
  • MACD
  • AGAE -0.01
  • NTRB 0.20
  • Stochastic Oscillator
  • AGAE 8.00
  • NTRB 93.73

About AGAE Allied Gaming & Entertainment Inc.

Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: